Hydrogen Sulfide Improves Survival After Cardiac Arrest and Cardiopulmonary Resuscitation via a Nitric Oxide Synthase 3–Dependent Mechanism in Mice
Background— Sudden cardiac arrest (CA) is one of the leading causes of death worldwide. We sought to evaluate the impact of hydrogen sulfide (H2S) on the outcome after CA and cardiopulmonary resuscitation (CPR) in mouse.
Methods and Results— Mice were subjected to 8 minutes of normothermic CA and resuscitated with chest compression and mechanical ventilation. Seven minutes after the onset of CA (1 minute before CPR), mice received sodium sulfide (Na2S) (0.55 mg/kg IV) or vehicle 1 minute before CPR. There was no difference in the rate of return of spontaneous circulation, CPR time to return of spontaneous circulation, and left ventricular function at return of spontaneous circulation between groups. Administration of Na2S 1 minute before CPR markedly improved survival rate at 24 hours after CPR (15/15) compared with vehicle (10/26; P=0.0001 versus Na2S). Administration of Na2S prevented CA/CPR-induced oxidative stress and ameliorated left ventricular and neurological dysfunction 24 hours after CPR. Delayed administration of Na2S at 10 minutes after CPR did not improve outcomes after CA/CPR. Cardioprotective effects of Na2S were confirmed in isolated-perfused mouse hearts subjected to global ischemia and reperfusion. Cardiomyocyte-specific overexpression of cystathionine γ-lyase (an enzyme that produces H2S) markedly improved outcomes of CA/CPR. Na2S increased phosphorylation of nitric oxide synthase 3 in left ventricle and brain cortex, increased serum nitrite/nitrate levels, and attenuated CA-induced mitochondrial injury and cell death. Nitric oxide synthase 3 deficiency abrogated the protective effects of Na2S on the outcome of CA/CPR.
Conclusions— These results suggest that administration of Na2S at the time of CPR improves outcome after CA possibly via a nitric oxide synthase 3–dependent signaling pathway.
- cardiopulmonary resuscitation
- heart arrest
- myocardial contraction
- nitric oxide synthase
Received November 17, 2008; accepted June 15, 2009.
Restoration of spontaneous circulation after prolonged whole body ischemia is an unnatural pathophysiological state created by successful cardiopulmonary resuscitation (CPR). According to recent epidemiological data, the in-hospital mortality rate after cardiac arrest (CA) was 55% to 71% in adults and children who regained any spontaneous circulation after CPR.1 Post-CA syndrome, including neurological dysfunction, myocardial damage, and “sepsis-like” systemic inflammation, is likely to contribute to the multisystem organ dysfunction and the ultimate demise of many victims.2 Although hypothermia has proven effective in clinical studies, no pharmacological agent yet tested has proven successful in improving outcome from CA/CPR.
Clinical Perspective on p 896
Hydrogen sulfide (H2S) is a colorless gas with a characteristic rotten-egg odor found in various natural and industrial sources.3 In mammalian tissues, H2S is generated through the degradation of l-cysteine mainly by 2 enzymes, cystathionine β-synthase (CBS) and cystathionine γ-lyase (CGL).4 Both CBS and CGL are expressed at high levels in liver, kidney, and pancreas, presumably for cysteine synthesis. CGL is also expressed in brain, heart, and smooth muscle.5,6 Although deficiency of CBS causes hyperhomocysteinemia, an established risk factor for cardiovascular disorders including sudden cardiac death, CGL deficiency causes cystathioninuria, an apparently benign condition albeit with an inconsistent and variable disease association.7
H2S exerts a host of biological effects on various targets, resulting in responses that range from cytotoxic to cytoprotective effects.5 Although breathing high concentrations of H2S is toxic,5 breathing low concentrations of H2S reversibly reduces metabolism in rodents and improves survival after hemorrhagic shock in rats.8–10 Although administration of NaHS has been shown to worsen cerebral ischemia11 and lipopolysaccharide-induced systemic inflammation,12 recent studies showed that administration of NaHS or Na2S can attenuate ischemia/reperfusion (IR) injury in heart,13–15 liver,16 and kidney.17 The protective effects of H2S appear to be mediated via antiapoptotic and/or anti-inflammatory effects. However, the impact of Na2S on the outcome of CA/CPR, which is complicated by whole body IR injury and systemic inflammation, remains to be elucidated. In the present study, we report that administration of Na2S at the time of CPR markedly improves myocardial and neurological function and survival after CA/CPR in mice.
After approval by the Massachusetts General Hospital Subcommittee on Research Animal Care, we studied 2- to 3-month-old age- and weight-matched male C57BL/6J wild-type and nitric oxide synthase 3 (NOS3)–deficient mice on a C57BL/6J background (NOS3−/−). We also studied 2- to 3-month-old male mice with cardiomyocyte-specific overexpression of CGL (CS-CGLtg)13 and their wild-type littermates (FVBN/J).
Sodium sulfide (Na2S; IK-1001) was a generous gift from Ikaria Inc (Seattle, Wash). Na2S was produced by using H2S gas (Matheson, Newark, Calif) as a starting material and was formulated to pH neutrality and iso-osmolarity. Na2S was diluted in normal (0.9%) saline to the desired concentration immediately before administration.
Mice were anesthetized with 100 μg/g ketamine and 0.25 μg/g fentanyl delivered by intraperitoneal injection and mechanically ventilated (Fio2=0.21; Minivent, Harvard Apparatus). Arterial blood pressure was measured via a left femoral arterial line. A saline-filled microcatheter (PE-10, Becton Dickinson) was inserted into the left femoral vein for drug and fluid administration. Blood pressure and needle-probe ECG monitoring data were recorded and analyzed with the use of a PC-based data acquisition system.
Murine CPR Model
CA was induced by administration of 0.08 mg/g potassium chloride through the femoral catheter and was confirmed by loss of arterial pressure and asystolic rhythm on ECG. After 8 minutes of CA, chest compressions were delivered with a finger at a rate of 340 to 360 beats per minute with resumption of mechanical ventilation (Fio2=1.0). Chest compressions were adjusted to provide a uniform rate seen on femoral artery pressure monitoring and a target femoral diastolic pressure of >20 mm Hg. Epinephrine was infused at 0.3 μg/min starting 30 seconds before CPR and continued until heart rate became >300 bpm. Core body temperature was maintained at 37°C by a warming lamp. Return of spontaneous circulation (ROSC) was defined as the return of sinus rhythm with a mean arterial pressure >40 mm Hg lasting at least 1 minute. Mice were weaned from mechanical ventilation at 1 hour after and extubated at 2 hours after CPR. In a subgroup of mice, at 24 hours after CPR, cardiac function was examined with a conductance pressure-volume catheter (SPR-839, Millar Instruments Inc) under anesthesia. Mice subjected to sham surgery that were not subjected to CA were used as controls. Study drug (Na2S) or vehicle was injected via the femoral venous line 1 minute before CPR. On the basis of pilot studies, we administered 0.55 mg/kg (7.0 μmol/kg) Na2S. Effects of delayed administration of Na2S at 10 minutes after the start of CPR (post-CPR Na2S) were examined in a subgroup of mice.
Assessment of Neurological Function
Neurological function was assessed at 24 hours after CA/CPR or sham surgery with the use of a previously reported neurological function scoring system with minor modifications (see Methods in the online-only Data Supplement).18,19
Effects of Na2S on Myocardial Function in Isolated-Perfused Mouse Heart
Mice were heparinized and anesthetized with the use of pentobarbital (60 mg/kg IP). The heart was removed quickly and mounted on a 20-gauge cannula in ice-cold perfusion buffer (a modified Krebs-Henseleit buffer, containing [in mmol/L] 118.5 NaCl, 24.9 NaHCO3, 11.2 glucose, 4 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2 sodium pyruvate, and 2.5 CaCl2). Retrograde perfusion was started with the use of perfusion buffer continuously gassed with 95% O2/5% CO2 at 37°C. A constant hydrostatic coronary pressure of 65 mm Hg was maintained throughout the experiment. The tip of an SPR-671 transducer (Millar Instruments, Houston, Tex) was placed in a saline-filled polyvinyl chloride balloon that was inserted into the left ventricle (LV). The balloon was inflated to obtain a diastolic pressure of 5 to 10 mm Hg, and LV pressure was monitored via the Millar transducer and continuously recorded. LV developed pressure, rate-pressure product, maximum and minimum rate of LV pressure change (dP/dtmax and dP/dtmin), and the time constant of isovolumic LV relaxation (τ) were calculated. Hearts were electrically paced at 7 Hz with the use of a Grass S88 stimulator (Grass Technologies, West Warwick, RI). Coronary flow rate was measured with an N1 in-line flowprobe and a T106 flowmeter (Transonic Systems, Ithaca, NY). After a 30-minute stabilization period, hearts were subjected to 20 minutes of ischemia followed by 60 minutes of reperfusion. Na2S (10 μmol/L) or vehicle was administered into the perfusate starting immediately or 40 seconds after the start of reperfusion and continued for 5 minutes. Myocardial function was measured for the first 60 minutes after reperfusion.
Measurement of Serum Nitrite/Nitrate
Concentrations of nitrite and nitrate were measured in serum samples obtained at 15 minutes after CA/CPR or sham surgery with a Nitrate/Nitrite Fluorometric Assay Kit (Cayman Chemical, Ann Arbor, Mich) according to the manufacturer’s instructions.
Mitochondrial Permeability Transition
Mouse heart mitochondria were isolated 15 minutes after CA/CPR or sham operation by differential centrifugation with the use of the MITO-ISO1 kit (Sigma-Aldrich, St Louis, Mo) following the manufacturer’s instructions. Mitochondrial permeability transition was measured by monitoring the decrease in absorbance at 540 nm associated with mitochondrial swelling, as described previously.20 Briefly, mitochondrial suspensions were diluted to a final concentration of 0.5 mg/mL in a buffer containing (in mmol/L) 200 mannitol, 70 sucrose, 10 HEPES, and 5 succinate (pH 7.4). After 2 minutes of stabilization, 400 μmol/L CaCl2 was added to induce mitochondrial permeability transition. The decrease in absorbance was monitored for 1000 seconds at room temperature with a spectrophotometer. The maximal rate of the absorbance decrease was obtained by linear regression over a 3-minute period.
Measurements of Peroxide Levels in Serum
Concentrations of hydrogen peroxide were measured in serum samples obtained at 5 minutes after CA/CPR or sham surgery with a QuantiChrom Peroxide Assay Kit (BioAssay Systems, Hayward, Calif) according to the manufacturer’s instructions. Detailed description of reagents and protocol for immunoblots and histological studies are provided in Methods in the online-only Data Supplement.
All data are expressed as mean±SEM. Normally distributed data were analyzed with the use of unpaired t test, 2-way repeated-measures ANOVA, or 1-way ANOVA with a Holm-Sidak or Bonferroni post hoc test. Neurological function scores of CS-CGLtg versus FVBN/J wild-type mice were compared by Mann-Whitney rank sum test because the values are not normally distributed. Difference in survival rate was analyzed by Gehan-Breslow test. Sigmastat 3.01a (Systat Software Inc, San Jose, Calif) and GraphPad Prism 5.0 (GraphPad Software Inc, La Jolla, Calif) were used for statistical analyses.
Na2S Improves Survival Rate After CA and CPR
The rate of ROSC was >95% in mice treated with either vehicle or Na2S. There was no difference between treatment groups in the CPR time to ROSC or the total epinephrine dose (Table I in the online-only Data Supplement). Although only 10 of 26 mice treated with vehicle survived 24 hours after CPR, all 15 mice treated with Na2S 1 minute before CPR survived 24 hours after CA and CPR (P=0.0001; Figure 1). In contrast, delayed administration of Na2S at 10 minutes after CPR did not improve the survival rate at 24 hours after CPR (5 of 11 survived; P=0.9 versus vehicle). Although formal long-term survival analysis was not done in the present study, in our pilot studies, >90% of mice treated with Na2S recovered completely by 72 hours after CPR and lived indefinitely. On the other hand, <20% of vehicle-treated mice survived 72 hours after CPR. Because delayed administration of Na2S did not improve survival compared with vehicle, neurological and myocardial function and tissue injury were compared between groups of mice that received vehicle or Na2S 1 minute before CPR.
Na2S Improved Neurological Function 24 Hours After CA and CPR
Although neurological function was depressed in surviving mice 24 hours after CA/CPR, it was better in Na2S-treated mice than in vehicle-treated mice (P<0.0001; Figure 2A).
Na2S Prevents Apoptosis in Brain After CA and CPR
Immunoblot analysis revealed that caspase 3 was activated at 15 minutes after CA/CPR in cerebral cortex of vehicle-treated mice (Figure 2B). The caspase 3 activation was markedly attenuated by Na2S. Histological studies revealed that the number of neurons containing cleaved caspase 3 in the CA1 region of the hippocampus was markedly increased at 24 hours after CA/CPR (Figure 2C and 2D). Similarly, the number of dead neurons identified by morphological criteria21 in the CA1 region was markedly increased at 72 hours after CA/CPR (Figure 2E and 2F). Administration of Na2S 1 minute before CPR decreased the numbers of cleaved caspase 3–positive or dead neurons in the hippocampus. Because phosphorylation of GSK-3β has been suggested to inhibit apoptosis, we examined phosphorylation status of GSK-3β in the brain cortex extracts. The neuroprotective effects of Na2S were associated with enhanced GSK-3β phosphorylation at Ser9 (Figure 2G). These results suggest that administration of Na2S 1 minute before CPR prevents apoptosis in the brain.
Na2S Prevents Myocardial Dysfunction After CA and CPR
There was no difference in heart rate and mean arterial pressure between mice treated with vehicle or Na2S at ROSC or 60 minutes after CPR (Supplemental Table I in the online-only Data Supplement). Twenty-four hours after CA/CPR, heart rate, LV end-systolic pressure, dP/dtmax, end-systolic elastance, and preload-recruitable stroke work were depressed in vehicle-treated mice compared with sham but not in Na2S-treated mice (Table). Myocardial mechanical efficiency (estimated by the ratio of end-systolic elastance to arterial elastance) was impaired (decreased ratio) in vehicle-treated mice but not in Na2S-treated mice (Table). These results show that administration of Na2S at the time of CPR prevents post-CA myocardial dysfunction 24 hours after CA/CPR.
Na2S Improves Myocardial Function After In Vitro IR
To examine the impact of Na2S on myocardial function after global IR, we studied the effects of Na2S in isolated-perfused mouse hearts. Myocardial function was depressed after 20 minutes of ischemia in vehicle-treated hearts. Administration of Na2S (10 μmol/L) starting at the time of reperfusion after 20 minutes of ischemia markedly improved the recovery of myocardial function (Figure 3A through 3F). Recovery of both systolic (dP/dtmax, LV developed pressure, and rate-pressure product) and diastolic (dP/dtmin and τ) myocardial function was markedly augmented by Na2S compared with vehicle. Na2S also improved the recovery of coronary flow. Of note, delaying the start of administration of Na2S by 40 seconds after the start of reperfusion abolished the protective effects of Na2S on myocardial function after IR (Figure I in the online-only Data Supplement). These results further support the concept that Na2S can preserve cardiac function after global myocardial IR when it is administered at the time of reperfusion.
Na2S Attenuates Oxidative Stress and Protects Mitochondria in the Heart After CA and CPR
CA accelerated the rate of Ca2+-induced mitochondrial swelling, a measure of mitochondrial permeability transition pore opening, compared with the mitochondria of sham-operated mice. Na2S prevented the acceleration of Ca2+-induced mitochondrial swelling in cardiac mitochondria after CA/CPR (Figure 4A and 4B). Na2S also prevented CA-induced increments in hydrogen peroxide levels in serum 5 minutes after CPR (Figure 4C). These results suggest that Na2S attenuates oxidative stress early after CA/CPR and protects cardiac mitochondria.
Cardiomyocyte-Specific Overexpression of CGL Improves Outcomes After CA and CPR
To examine the impact of endogenously produced H2S in the heart on the recovery from CA/CPR, we studied CS-CGLtg mice, which have been characterized extensively and display increased H2S production in the heart.13 Compared with their wild-type littermates, CS-CGLtg mice had a markedly shorter CPR time to ROSC (516±62 versus 331±24 seconds; P=0.016), required a smaller dose of epinephrine to achieve ROSC (1.5±0.2 versus 0.9±0.1 μg; P=0.015), and had a higher mean arterial pressure at 60 minutes after CPR (28±2 versus 35±3 mm Hg; P=0.046). Additionally, CS-CGLtg mice had markedly improved neurological function (8±1 [median=7] versus 5±1 [median=4.5]; P=0.048 by Mann-Whitney rank sum test) and survival rate (8 of 11 versus 4 of 13; P=0.03; Figure 5) 24 hours after CA/CPR. These results suggest that augmented cardiac H2S levels facilitated recovery after CA/CPR.
Na2S Increases Phosphorylation of Akt and AMP-Activated Protein Kinase α After CA and CPR
Because Akt- and AMP-activated protein kinase (AMPK)–dependent signal contributes to cell survival in variety of pathological conditions,22,23 we sought to investigate the role of Akt and AMPK in the protective effects of Na2S. CA and CPR increased Akt phosphorylation in LV compared with sham-operated mice (Figure 6A). Administration of Na2S 1 minute before CPR increased Akt phosphorylation at Ser473 compared with vehicle both in the LV and brain after CA/CPR (Figure 6A and 6B). CA and CPR decreased phosphorylation of NOS3 at Ser1179 in the LV and brain (Figure 6C and 6D). Administration of Na2S prevented the dephosphorylation of NOS3 at Ser1179 both in LV and brain after CA/CPR. Similarly, CA/CPR-induced dephosphorylation of AMPKα at Thr172 was prevented by Na2S in the brain (Figure 6E). Of note, delayed administration of Na2S at 10 minutes after CPR (post-CPR Na2S) failed to increase the phosphorylation of Akt, NOS3, and AMPKα compared with vehicle after CA/CPR. These observations suggest that protective effects of Na2S on organ function are associated with activation of Akt- and/or AMPKα-dependent prosurvival signals.
Na2S Prevents Reduction of Nitrite/Nitrate Levels After CA and CPR
To examine whether the protective effects of Na2S were associated with augmented NO production, we measured serum nitrite and nitrate levels at 15 minutes after CA/CPR. Compared with sham-operated mice (4.7±0.8 μmol/L), nitrite/nitrate levels were decreased in vehicle-treated mice (3.2±0.8 μmol/L; P<0.01 versus sham) but not in Na2S-treated mice (4.3±0.2 μmol/L; P=0.35 versus sham, P<0.05 versus vehicle-treated mice) 15 minutes after CA/CPR.
Na2S Does Not Improve Outcome of CA and CPR in NOS3-Deficient Mice
To elucidate the role of NOS3/NO in the protective effects of Na2S, we examined whether Na2S improves outcomes of CA/CPR in NOS3−/− mice. Only 1 of 7 NOS3−/− mice survived 24 hours after CA/CPR, and administration of Na2S 1 minute before CPR did not improve the survival rate in NOS3−/− mice (1 of 7 survived; Figure 6F). These results suggest that the protective effects of Na2S on the outcome of CA/CPR require NOS3.
The present study revealed that administration of Na2S at the time of CPR markedly improves myocardial and neurological function and survival after CA/CPR in mice. The neuroprotective effects of Na2S were associated with attenuated CA/CPR-induced caspase 3 activation in the brain. Global myocardial IR in isolated-perfused heart model confirmed the protective effects of Na2S. Administration of Na2S also prevented systemic oxidative stress and acceleration of mitochondrial permeability transition in the heart. Enhanced endogenous H2S production by cardiomyocyte-specific overexpression of CGL improved outcomes after CA/CPR. The salutary impact of Na2S treatment on the outcome of CA/CPR was associated with preserved serum nitrite and nitrate levels and enhanced phosphorylation of Akt and NOS3 in the brain and heart and AMPKα and GSK-3β in the brain. Finally, NOS3 deficiency abrogated the protective effects of Na2S on the outcome of CA/CPR. Taken together, these observations suggest that H2S confers organ protection and improves survival after CA/CPR at least in part via an NOS3-dependent mechanism.
The majority of research on CA over the past half century has focused on improving the rate of ROSC, and significant progress has been made. However, many patients succumb to the post-CA syndrome after successful resuscitation. The present study was designed to investigate whether H2S could improve the outcome after “successful” resuscitation. Although there was no difference in the rate of ROSC or CPR time to ROSC, mice that received Na2S immediately before CPR showed a markedly higher survival rate at 24 hours than did mice that received vehicle before CPR or Na2S 10 minutes after CPR. These observations suggest that administration of Na2S at the time of CPR improved outcomes at 24 hours after CA by preventing the development of post-CA organ injury and dysfunction after ROSC.
The present results suggest that Na2S can protect against the development of post-CA neurological dysfunction and injury when administered at the time of CPR (Figure 2A). CA and CPR activated caspase 3 and induced cell death in the brain of vehicle-treated mice. In contrast, the improved neurological function at 24 hours after CPR in mice treated with Na2S was associated with marked attenuation of caspase 3 activation and cell death in the brain after CPR. Previously, Qu and colleagues11 showed that administration of NaHS increased brain infarct volume after permanent middle cerebral artery occlusion. Differences in the models and the higher dose of NaHS (180 μmol/kg of NaHS, equivalent to ≈90 μmol/kg of Na2S24) used in the Qu study compared with the present study (7 μmol/kg of Na2S) may explain the conflicting results of these studies.16 Proapoptotic effects of relatively high concentrations of H2S have also been reported in pancreas.25 Nonetheless, our results suggest that physiological level of H2S can have important protective effects on ischemic brain injury.
To examine the molecular mechanisms responsible for the antiapoptotic effects of Na2S, we tested whether Na2S promotes Akt- or AMPK-dependent prosurvival signals in the brain. We found that Na2S increased phosphorylation of Akt and GSK-3β in the brain cortex. Akt-dependent phosphorylation of GSK-3β inhibits GSK-3β activity and thereby decreases apoptosis.26,27 Similarly, administration of Na2S 1 minute before CPR prevented the CA/CPR-induced dephosphorylation of AMPKα and NOS3. It has been reported that activation of cGMP-dependent protein kinase may confer cardioprotection via GSK-3β.27 It is conceivable that Akt- and/or AMPKα-dependent NOS3 activation activates the cGMP-dependent protein kinase–dependent neuroprotective mechanism via GSK-3β phosphorylation in our model.
Similar to neurological function, myocardial function at 24 hours after CA/CPR was also improved by administration of Na2S (Table). These results are reinforced by our findings that administration of Na2S starting immediately after reperfusion, but not when administered 40 seconds after reperfusion, markedly improved myocardial function in the isolated-perfused mouse heart subjected to global IR. These results are consistent with a previous report that NaHS was cardioprotective in isolated rat hearts.15 The relatively narrow temporal window of opportunity for Na2S to improve the outcome of CA/CPR is consistent with previous studies of ischemic postconditioning. For example, Cohen and colleagues28 recently reported that delay of the onset of postconditioning by only 1 minute aborts protection in rabbit hearts.
Mitochondrial permeability transition is a central mechanism of IR-induced death.20 Na2S prevented CA/CPR-induced acceleration of Ca2+-induced mitochondrial swelling, a measure of mitochondrial permeability transition, in LV mitochondria. The beneficial effect of Na2S was associated with attenuated oxidative stress indicated by decreased serum hydrogen peroxide levels (Figure 4C). Oxidative stress has been shown to trigger mitochondrial permeability transition.29 These observations suggest that the cardioprotective effects of Na2S may be mediated by inhibition of mitochondrial permeability transition.
Cardioprotective effects of endogenous H2S after IR have been suggested by studies showing deleterious effects of CGL inhibitors30 and protective effects of CS-CGLtg13 in myocardial IR. Our observation that CS-CGLtg mice had a markedly shorter CPR time to ROSC suggests that endogenous H2S promotes the recovery of myocardial function after CA/CPR. Although CS-CGLtg mice also had improved neurological function and survival rate 24 hours after CA/CPR, these findings may be due to the shortened CPR time to ROSC, as well as possible neuroprotective effects of endogenously produced H2S. Nonetheless, these observations support an important salutary effect of endogenous H2S production on the outcomes of CA/CPR.
Improved myocardial function in Na2S-treated mice was associated with increased phosphorylation of Akt and NOS3 in the LV and elevated serum levels of nitrite plus nitrate combined compared with vehicle-treated mice 15 minutes after CA/CPR. In contrast, delayed administration of Na2S at 10 minutes after CPR did not increase the phosphorylation of Akt and NOS3 in the LV and failed to improve the outcome of CA/CPR. Furthermore, NOS3 deficiency abrogated the protective effects of Na2S on the outcome of CA/CPR. In a previous study, we found that NOS3 deficiency markedly worsened outcomes of CA/CPR, suggesting a salutary role of NOS3 on the outcome of CA/CPR.19 Taken together, these results suggest a critical role of NOS3/NO in the mechanisms responsible for the protective effects of Na2S after CA/CPR.
In summary, the present study revealed robust protective effects of Na2S on the outcome of CA/CPR in mouse. Administration of Na2S 1 minute before the start of CPR markedly improved myocardial and neurological function and survival 24 hours after normothermic CA/CPR. These observations, if extrapolated to human beings, may be highly clinically relevant because they suggest that Na2S administration can improve the outcome of CA at the time of CPR when intravenous access is obtained. Further studies are warranted to elucidate the impact of exogenous and endogenous H2S on the longer-term outcome of CA/CPR complicated by post-CA syndrome.
The authors thank Ikaria Inc for generously providing IK-1001 and Dr Christophe Adrie for valuable advice.
Sources of Funding
This work was supported by National Institutes of Health grants HL92141 (Drs Lefer and Elrod), HL92737 (Dr Elrod), HL70896 (Dr Bloch), HL71987 (Dr Ichinose), and GM79360 (Dr Ichinose) and the Gas-Enabled Medical Innovation Fund (Dr Ichinose).
Nadkarni VM, Larkin GL, Peberdy MA, Carey SM, Kaye W, Mancini ME, Nichol G, Lane-Truitt T, Potts J, Ornato JP, Berg RA, for the National Registry of Cardiopulmonary Resuscitation Investigators. First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA. 2006; 295: 50–57.
Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P, Spaulding C, Dhainaut JF, Cavaillon JM. Successful cardiopulmonary resuscitation after cardiac arrest as a “sepsis-like” syndrome. Circulation. 2002; 106: 562–568.
Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J. 1982; 15; 206: 267–277.
Blackstone E, Morrison M, Roth MB. H2S induces a suspended animation-like state in mice. Science. 2005; 308: 518.
Qu K, Chen CPLH, Halliwell B, Moore PK, Wong PTH. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke. 2006; 37: 889–893.
Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, Moore PK. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005; 19: 1196–1198.
Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A. 2007; 104: 15560–15565.
Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Sellke FW. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg. 2008; 33: 906–913.
Yong QC, Lee SW, Foo CS, Neo KL, Chen X, Bian JS. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol. 2008; 295: H1330–H1340.
Tripatara P, SA Patel N, Collino M, Gallicchio M, Kieswich J, Castiglia S, Benetti E, Stewart KN, Brown PA, Yaqoob MM, Fantozzi R, Thiemermann C. Generation of endogenous hydrogen sulfide by cystathionine γ-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest. 2008; 88: 1038–1048.
Abella BS, Zhao D, Alvarado J, Hamann K, Vanden Hoek TL, Becker LB. Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation. 2004; 109: 2786–2791.
Nishida T, Yu JD, Minamishima S, Sips PY, Searles RJ, Buys ES, Janssens S, Brouckaert P, Bloch KD, Ichinose F. Protective effects of nitric oxide synthase 3 and soluble guanylate cyclase on the outcome of cardiac arrest and cardiopulmonary resuscitation in mice. Crit Care Med. 2009; 37: 256–262.
Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res. 2004; 61: 448–460.
Yang G, Yang W, Wu L, Wang R. H2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting beta cells. J Biol Chem. 2007; 282: 16567–16576.
Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res. 2002; 90: 377–379.
Das A, Xi L, Kukreja RC. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3β. J Biol Chem.. 2008; 283: 29572–29585.
Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation. 2007; 115: 1895–1903.
Sudden cardiac arrest is one of the leading causes of death worldwide. Despite advances in cardiopulmonary resuscitation (CPR) methods, including the introduction of the automatic electric defibrillator and therapeutic hypothermia, 60% to 80% of these arrests result in immediate death, and of the remaining, only ≈5% are successfully resuscitated to the extent that they are returned to productive lives. Poor outcome from cardiac arrest is at least partly due to the lack of therapeutic possibilities. In this study, we examined effects of hydrogen sulfide, a gaseous molecule with multifaceted protective properties, on the outcome of cardiac arrest and CPR in mice. We found that administration of sodium sulfide, a hydrogen sulfide donor, 1 minute before CPR markedly improved neurological and myocardial function and survival after 8 minutes of cardiac arrest in mice. These observations, if extrapolated to human beings, may be highly clinically relevant because they suggest that sodium sulfide administration can improve the outcome of sudden cardiac arrest at the time of CPR when intravenous access is obtained. Further studies are warranted to elucidate the impact of exogenous and endogenous hydrogen sulfide on the longer-term outcome of cardiac arrest and CPR complicated by post–cardiac arrest syndrome.
The online-only Data Supplement is available with this article at http://circ.ahajournals.org/cgi/content/full/CIRCULATIONAHA.108.833491/DC1.